PAPER Seritan AL, Rienas C, Duong T, Delucchi K, Ostrem JL31117906
PAPER Demirev AV, Song HL, Cho MH, Cho K, Peak JJ, Yoo HJ, Kim DH, Yoon SY31121321
PAPER Buchmann N, Fink A, Tegeler C, Demuth I, Doblhammer G, Steinhagen-Thiessen E
Different treatment forms of type II diabetes and the risk of dementia in German health claims data.Acta Diabetol. 2019 Sep;56(9):995-1003. Epub 2019 May 22 PubMed: 31119454
PAPER Xu W, Zhang C, Li JQ, Tan CC, Cao XP, Tan L, Yu JT, Alzheimer’s Disease Neuroimaging Initiative
Age-related hearing loss accelerates cerebrospinal fluid tau levels and brain atrophy: a longitudinal study.Aging (Albany NY). 2019 May 22;11(10):3156-3169. PubMed: 31118310
PAPER Pardo E, Barake F, Godoy JA, Oyanadel C, Espinoza S, Metz C, Retamal C, Massardo L, Tapia-Rojas C, Inestrosa NC, Soza A, González A
GALECTIN-8 Is a Neuroprotective Factor in the Brain that Can Be Neutralized by Human Autoantibodies.Mol Neurobiol. 2019 Nov;56(11):7774-7788. Epub 2019 May 22 PubMed: 31119556
PAPER Haghparast E, Sheibani V, Abbasnejad M, Esmaeili-Mahani S
Apelin-13 attenuates motor impairments and prevents the changes in synaptic plasticity-related molecules in the striatum of Parkinsonism rats.Peptides. 2019 Jul;117:170091. Epub 2019 May 21 PubMed: 31121196
PAPER Wang Y, Wang Q, Li J, Lu G, Liu Z
Glutamine Improves Oxidative Stress through the Wnt3a/β-Catenin Signaling Pathway in Alzheimer's Disease In Vitro and In Vivo.Biomed Res Int. 2019;2019:4690280. Epub 2019 Apr 16 PubMed: 31119171
PAPER Saleem U, Raza Z, Anwar F, Ahmad B, Hira S, Ali T
Experimental and Computational Studies to Characterize and Evaluate the Therapeutic Effect of Albizia lebbeck (L.) Seeds in Alzheimer's Disease.Medicina (Kaunas). 2019 May 21;55(5) PubMed: 31117312
GRANT Friday, May 24, 2019- 14:45 National Institute of General Medical Sciences October 2, 2019; October 2, 2020; October 4, 2021, by 5 p.m. local time of applicant organization. All types of applications allowed for this funding opportunity announcement are ...
Limited Competition: NIA Genome Center for Alzheimer's Disease (U54 Clinical Trial Not Allowed) (PAR-19-288)
GRANT Friday, May 24, 2019- 14:45 National Institute on Aging NIH intends to fund an estimate of one award, corresponding to approximately $2.5 million in direct costs, for fiscal year 2020. Future year amounts will depend on annual appropriations. Standard ...
Understanding Senescence in Brain Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed) (RFA-AG-20-025)
GRANT Friday, May 24, 2019- 14:45 National Institute on Aging NIA intends to commit $4 million in FY 2020 to fund nine to 11 awards. October 17, 2019, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding ...
SCAN: Standardized Centralized Alzheimer's and Related Dementias Neuroimaging (U24 Clinical Trials Not Allowed) (RFA-AG-20-043)
GRANT Friday, May 24, 2019- 14:45 National Institute on Aging NIH intends to commit $1.5 million in FY 2020 to fund one award. Future year amounts will depend on annual appropriations. July 22, 2019, by 5 p.m. local time of applicant organization. All types of ...
Rare Disease Clinical Outcome Assessment Consortium (U01 Clinical Trial Not Allowed) (RFA-FD-19-029)
GRANT Friday, May 24, 2019- 14:45 Food and Drug Administration FDA/Center for Drug Evaluation and Research intends to fund up to $300,000 for fiscal year 2019 in support of this program. July 29, 2019 by 11:59 p.m. Eastern Time. Late applications will not be ...
CONFERENCE COVERAGE 2019-05-24 Conference Coverage About 140 scientists gathered in Rungstedgaard, north of Copenhagen, Denmark, May 5–9 for the biannual Brain Conference organized by the Federation of European Neuroscience Societies and the Lundbeck Foundation. Co-chaired by Beth ...
RESEARCH NEWS 2019-05-24 Research News Does neurogenesis keep the brain sharp? This unsettled debate is getting new fuel this week. In the May 23 Cell Stem Cell online, researchers led by Orly Lazarov at the University of Illinois, Chicago, report that they can find newborn ...